Cargando…
Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines
The drug-induced proliferation (DIP) rate is a metric of in vitro drug response that avoids inherent biases in commonly used metrics such as 72 h viability. However, DIP rate measurements rely on direct cell counting over time, a laborious task that is subject to numerous challenges, including the n...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037430/ https://www.ncbi.nlm.nih.gov/pubmed/35443861 http://dx.doi.org/10.1080/15384047.2022.2065182 |
_version_ | 1784693730600550400 |
---|---|
author | Wandishin, Clayton M. Robbins, Charles John Tyson, Darren R. Harris, Leonard A. Quaranta, Vito |
author_facet | Wandishin, Clayton M. Robbins, Charles John Tyson, Darren R. Harris, Leonard A. Quaranta, Vito |
author_sort | Wandishin, Clayton M. |
collection | PubMed |
description | The drug-induced proliferation (DIP) rate is a metric of in vitro drug response that avoids inherent biases in commonly used metrics such as 72 h viability. However, DIP rate measurements rely on direct cell counting over time, a laborious task that is subject to numerous challenges, including the need to fluorescently label cells and automatically segment nuclei. Moreover, it is incredibly difficult to directly count cells and accurately measure DIP rates for cell populations in suspension. As an alternative, we use real-time luminescence measurements derived from the cellular activity of NAD(P)H oxidoreductase to efficiently estimate drug response in both adherent and suspension cell populations to a panel of known anticancer agents. For the adherent cell lines, we collect both luminescence reads and direct cell counts over time simultaneously to assess their congruency. Our results demonstrate that the proposed approach significantly speeds up data collection, avoids the need for cellular labels and image segmentation, and opens the door to significant advances in high-throughput screening of anticancer drugs. |
format | Online Article Text |
id | pubmed-9037430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-90374302022-04-26 Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines Wandishin, Clayton M. Robbins, Charles John Tyson, Darren R. Harris, Leonard A. Quaranta, Vito Cancer Biol Ther Research Paper The drug-induced proliferation (DIP) rate is a metric of in vitro drug response that avoids inherent biases in commonly used metrics such as 72 h viability. However, DIP rate measurements rely on direct cell counting over time, a laborious task that is subject to numerous challenges, including the need to fluorescently label cells and automatically segment nuclei. Moreover, it is incredibly difficult to directly count cells and accurately measure DIP rates for cell populations in suspension. As an alternative, we use real-time luminescence measurements derived from the cellular activity of NAD(P)H oxidoreductase to efficiently estimate drug response in both adherent and suspension cell populations to a panel of known anticancer agents. For the adherent cell lines, we collect both luminescence reads and direct cell counts over time simultaneously to assess their congruency. Our results demonstrate that the proposed approach significantly speeds up data collection, avoids the need for cellular labels and image segmentation, and opens the door to significant advances in high-throughput screening of anticancer drugs. Taylor & Francis 2022-04-21 /pmc/articles/PMC9037430/ /pubmed/35443861 http://dx.doi.org/10.1080/15384047.2022.2065182 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Wandishin, Clayton M. Robbins, Charles John Tyson, Darren R. Harris, Leonard A. Quaranta, Vito Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
title | Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
title_full | Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
title_fullStr | Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
title_full_unstemmed | Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
title_short | Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
title_sort | real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037430/ https://www.ncbi.nlm.nih.gov/pubmed/35443861 http://dx.doi.org/10.1080/15384047.2022.2065182 |
work_keys_str_mv | AT wandishinclaytonm realtimeluminescenceenablescontinuousdrugresponseanalysisinadherentandsuspensioncelllines AT robbinscharlesjohn realtimeluminescenceenablescontinuousdrugresponseanalysisinadherentandsuspensioncelllines AT tysondarrenr realtimeluminescenceenablescontinuousdrugresponseanalysisinadherentandsuspensioncelllines AT harrisleonarda realtimeluminescenceenablescontinuousdrugresponseanalysisinadherentandsuspensioncelllines AT quarantavito realtimeluminescenceenablescontinuousdrugresponseanalysisinadherentandsuspensioncelllines |